RareDisease

Novo Nordisk Makes $2.1 Billion Rare-Disease Bet After Losing Ground in Obesity Race

This article was first published on: GuruFocus. Novo Nordisk (NYSE:NVO) energetic It was quick to regain momentum by making strategic…